The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The efficacy and safety of tislelizumab plus bevacizumab and chemotherapy as first line therapy in patients with persistent, recurrent, or metastatic cervical cancer: A multicenter, phase II study.
 
Jianqing Zhu
No Relationships to Disclose
 
Mei Pan
No Relationships to Disclose
 
Hao Yu
No Relationships to Disclose
 
Hongtu Chao
No Relationships to Disclose
 
Youguo Chen
No Relationships to Disclose
 
Hongqin Zhao
No Relationships to Disclose
 
Shuhuai Niu
No Relationships to Disclose
 
Yuhua Gao
No Relationships to Disclose
 
Qiang Wen
No Relationships to Disclose